Skip to main content
Clinical Trials/ISRCTN69157693
ISRCTN69157693
Active, not recruiting
未知

Memokath 051 Double cone metallic stents in treating intractable ureteric obstruction

South Tees Hospitals NHS Foundation Trust0 sites100 target enrollmentJanuary 31, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
South Tees Hospitals NHS Foundation Trust
Enrollment
100
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 31, 2023
End Date
September 30, 2026
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Dependent on JJ stent for management of unilateral or bilateral ureteric obstruction
  • 2\. Benign or malignant obstruction
  • 3\. Life expectancy of more than 2 years
  • 4\. Renal unit function of more than 20, as assessed by nuclear medicine scan
  • 5\. Normal ureter below and above the level of obstruction as observed by retrograde pyelogram or ureteroscopy
  • 6\. Stricture not suitable or patient unfit for reconstructive surgery (OR patient choice as documented in clinic letter or medical notes)
  • 7\. Fit to undergo retrograde MK\-051 insertion under general or regional anaesthesia

Exclusion Criteria

  • 1\. Age less than 18 years
  • 2\. Allergy to nickel
  • 3\. Renal unit function less than 20, as assessed by nuclear medicine scan
  • 4\. Pelvic ureteric junction (PUJ) involved in stricture
  • 5\. Vesico\-ureteric junction (VUJ) involved in stricture
  • 6\. Primary PUJ obstruction or Mega Ureter
  • 7\. Not on JJ stent
  • 8\. Life expectancy less than 2 years
  • 9\. Previous active stone (stones present in the kidney, metabolic stone disease, forming stones within 2 years before recruitment)
  • 10\. Disease that requires ureteric instrumentation for treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials